New hope for kids with leukemia that Won't quit: pioneering cell therapy trial begins
NCT ID NCT06709469
Summary
This early-stage trial is testing the safety and feasibility of two new types of CAR-T cell therapy for children and young adults with leukemia that has come back or hasn't responded to standard treatments. One therapy targets a common form of B-cell leukemia, while the other is a novel approach for a rarer, harder-to-treat T-cell form. The main goal is to see if these treatments can be made safely and are tolerable for patients who have very few other options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario La Paz
RECRUITINGMadrid, Madrid, 28046, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.